Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial

老年人的衰老、认知和听力评估 (ACHIEVE) 随机试验

基本信息

  • 批准号:
    9986336
  • 负责人:
  • 金额:
    $ 38.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-06-01 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

Novel approaches to reduce the risk of age-related cognitive decline and Alzheimer's disease and related dementias (ADRD) in older adults are urgently needed given the aging of the population. Epidemiologic studies demonstrate that peripheral hearing loss in older adults is strongly and independently associated with accelerated cognitive decline and incident dementia. Hypothesized mechanistic pathways underlying this observed association include the effects of poor hearing and distorted peripheral encoding of sound on cognitive load, brain structure/function, and/or reduced social engagement. Importantly, these pathways may be modifiable with comprehensive hearing loss treatment consisting of the use of hearing technologies (hearing aids, other integrated hearing assistive devices) and rehabilitative training. The ACHIEVE trial will recruit 70-84 year-old cognitively-normal older adults with hearing loss who will be randomized 1:1 to the hearing intervention (hearing needs assessment, fitting of hearing devices, education/counseling) or control intervention (individualized successful aging education sessions with a health educator covering healthy aging topics). This trial will have 90% power to detect a net effect size of 0.26 for the difference in cognitive change between the hearing intervention vs successful aging intervention at 3 years follow-up (corresponding to a 35% slowing in the annual rate of cognitive decline). The ACHIEVE trial has the following aims: Aim 1 To determine ‐‐ the effect of hearing rehabilitative intervention versus a successful aging control intervention on rates of cognitive decline (primary outcome measure) in 70 84 year old cognitively-normal older adults with hearing loss. Aim 2 To determine the effect of hearing rehabilitative intervention versus a successful aging control intervention on secondary outcome measures of adjudicated incident dementia, physical and social functioning, health-related quality of life, and physical activity. The ACHIEVE trial began recruitment in January 2018 and reached the target N of 850 on July 17, 2019. This application for an administrative supplement to the ACHIEVE randomized trial is to support an increase in the sample size of the ACHIEVE study from the original target of N = 850 up to potentially N ~ 1000. An extension in recruitment is consistent with recent discussions from the ACHIEVE DSMB which convened on June 27, 2019 and “supports consideration of a modest extension of the planned enrollment period to provide additional robustness of the study design to possible violations in the assumptions used in the power calculations”.
减少与年龄相关的认知下降和阿尔茨海默氏病及相关风险的新方法 迫切需要老年人的痴呆症(ADRD)才能使人口老龄化。流行病学研究 证明老年人的外围听力损失与 加速认知能力下降和事件痴呆症。假设的机械途径 观察到的关联包括听力不良和声音外围编码的影响 认知负载,大脑结构/功能和/或社会参与减少。重要的是,这些途径可能 通过使用听力技术的全面听力损失治疗进行修改 (助听器,其他集成的听力辅助设备)和康复培训。实现审判将 招募70-84岁的认知正常老年人听力损失,他们将被随机分为1:1 听力干预(听力需求评估,听力设备的安装,教育/咨询)或控制 干预措施(通过健康衰老的健康教育,个性化的成功衰老教育课程 主题)。该试验将具有90%的功率来检测认知变化差异的净效应大小为0.26 在3年随访时,听力干预与成功的老化干预措施之间(相当于35% 认知能力下降的年度速度放缓)。实现试验具有以下目的:目标1确定 - 听力康复干预与成功的衰老控制干预措施的影响 70 84岁的认知衰落(主要结局指标)认知正常的老年人有听力 损失。目标2以确定听力康复干预与成功衰老控制的效果 干预调整事件痴呆,身体和社会的次要结局指标 功能,与健康相关的生活质量和体育锻炼。一月份的审判开始招聘 2018年,并于2019年7月17日达到850的目标n。 实现随机试验是支持从 n = 850至潜在n〜1000的原始目标。募集的扩展与最近 2019年6月27日召集的成就DSMB的讨论,“支持考虑 计划的入学期限适度的扩展,以提供研究设计的额外鲁棒性 在电源计算中使用的假设中可能违规”。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEF CORESH其他文献

JOSEF CORESH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEF CORESH', 18)}}的其他基金

Resource Development Core
资源开发核心
  • 批准号:
    10747706
  • 财政年份:
    2023
  • 资助金额:
    $ 38.98万
  • 项目类别:
Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study
老年人衰老和认知健康评估 (ACHIEVE) 随机研究中听力干预对大脑健康的长期影响
  • 批准号:
    10680434
  • 财政年份:
    2022
  • 资助金额:
    $ 38.98万
  • 项目类别:
Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study
老年人衰老和认知健康评估 (ACHIEVE) 随机研究中听力干预对大脑健康的长期影响
  • 批准号:
    10418325
  • 财政年份:
    2022
  • 资助金额:
    $ 38.98万
  • 项目类别:
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A
社区动脉粥样硬化风险 (ARIC) 研究 - 现场中心 - 任务令 01,任务区 A
  • 批准号:
    10788250
  • 财政年份:
    2021
  • 资助金额:
    $ 38.98万
  • 项目类别:
THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER - TASK ORDER 01, TASK AREA A
社区动脉粥样硬化风险 (ARIC) 研究 - 现场中心 - 任务令 01,任务区 A
  • 批准号:
    10620984
  • 财政年份:
    2021
  • 资助金额:
    $ 38.98万
  • 项目类别:
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults
综合组学、慢性肾病和老年人的不良后果
  • 批准号:
    10163839
  • 财政年份:
    2020
  • 资助金额:
    $ 38.98万
  • 项目类别:
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults
综合组学、慢性肾病和老年人的不良后果
  • 批准号:
    10368118
  • 财政年份:
    2020
  • 资助金额:
    $ 38.98万
  • 项目类别:
ARIC - JHU FIELD CENTER - DIVERSITY SUPPLEMENT
ARIC - JHU 野外中心 - 多样性补充
  • 批准号:
    10054600
  • 财政年份:
    2019
  • 资助金额:
    $ 38.98万
  • 项目类别:
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial
老年人的衰老、认知和听力评估 (ACHIEVE) 随机试验
  • 批准号:
    9287053
  • 财政年份:
    2017
  • 资助金额:
    $ 38.98万
  • 项目类别:
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
IGF::OT::IGF 动脉粥样硬化风险社区 - 现场中心 - 核心研究操作
  • 批准号:
    10329837
  • 财政年份:
    2016
  • 资助金额:
    $ 38.98万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

KLOTHO and Resilience to Synaptic Dysfunction in Preclinical AD
KLOTHO 和临床前 AD 中突触功能障碍的恢复力
  • 批准号:
    10587987
  • 财政年份:
    2023
  • 资助金额:
    $ 38.98万
  • 项目类别:
A Stage 1 Pilot Test for Feasibility and Efficacy of a Multi-Level Intervention To Increase Physical Activity in Adults with Intellectual Disability: Step it Up +
第一阶段试点测试多层次干预措施的可行性和有效性,以增加智力障碍成人的体力活动:加快步伐
  • 批准号:
    10585633
  • 财政年份:
    2023
  • 资助金额:
    $ 38.98万
  • 项目类别:
Examining Sleep, Circadian Rhythms, and Cognitive Functioning in Older Adults at Risk of Dementia
检查有痴呆风险的老年人的睡眠、昼夜节律和认知功能
  • 批准号:
    10606971
  • 财政年份:
    2023
  • 资助金额:
    $ 38.98万
  • 项目类别:
Home Alone: Developing a Home-Based Intervention for People with Cognitive Impairment Who Live Alone
独自在家:为独居认知障碍患者制定家庭干预措施
  • 批准号:
    10590347
  • 财政年份:
    2023
  • 资助金额:
    $ 38.98万
  • 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
  • 批准号:
    10717111
  • 财政年份:
    2023
  • 资助金额:
    $ 38.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了